Lesa Fuller
Acute Care · Wichita, KSNPI 1669136479
Payments from drug & device makers
What this record shows
Medtronic accounts for 82.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $3,537 and has fallen 87.5% since, to $441 in 2025. Among acute care clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $75.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Novartis$286
- E.r. Squibb & Sons, L.L.C.$256
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$205
- Kiniksa Pharmaceuticals, Ltd.$167
- Boston Scientific$141
- plus $586 from 10 others
What the payments were for
- Travel & lodging$5,13856%
- Food & beverage$4,09444%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 62 | $7,591 |
| Novartis | 11 | $286 |
| E.r. Squibb & Sons, L.L.C. | 15 | $256 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $205 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $167 |
| Boston Scientific | 1 | $141 |
| Abiomed | 1 | $136 |
| Bayer | 4 | $132 |
| Sumitomo Pharma America, Inc. | 1 | $117 |
| Merck | 3 | $44 |
| Amgen | 2 | $33 |
| AstraZeneca | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,143
- Micra$470
- SYMPLICITY G3$239
- WATCHMAN Access System$141
- Impella$136
- ARCALYST$135
- CAMZYOS$123
- LINQ II$122
- LEQVIO$117
- GEMTESA$117
- Kerendia$109
How this compares
$9,231 in reported general payments places this provider in the 95th percentile of 113 acute care providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 77 | $524 |
| Sertraline Hcl | 15 | $263 |
| Metoprolol Tartrate | 17 | $105 |
| Carvedilol | 14 | $100 |
| Atorvastatin Calcium | 25 | $77 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $65 |
| Lisinopril | 24 | $22 |
| Furosemide | 13 | $17 |
| Amlodipine Besylate | 11 | $1 |
Paid to pharmacies, not to this prescriber.
Other acute care in Wichita
- Kimberly FloryWichita$5K
- Gwendolyn WarwickWichita$5K
- Amy StutzmanWichita$4K
- Lina ChengWichita$4K
- Megan SilversWichita$3K
- Ryan PrebbleWichita$3K
- Rachel ReedWichita$3K
- Jill WettsteinWichita$2K
- Michelle WardenWichita$2K
- Leighann PersondekWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.